191 related articles for article (PubMed ID: 31437703)
1. Normalization of EEG in depression after antidepressant treatment with sertraline? A preliminary report.
van der Vinne N; Vollebregt MA; Boutros NN; Fallahpour K; van Putten MJAM; Arns M
J Affect Disord; 2019 Dec; 259():67-72. PubMed ID: 31437703
[TBL] [Abstract][Full Text] [Related]
2. EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.
Arns M; Gordon E; Boutros NN
Clin EEG Neurosci; 2017 Jan; 48(1):33-40. PubMed ID: 26674366
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
[TBL] [Abstract][Full Text] [Related]
4. Stability of frontal alpha asymmetry in depressed patients during antidepressant treatment.
van der Vinne N; Vollebregt MA; van Putten MJAM; Arns M
Neuroimage Clin; 2019; 24():102056. PubMed ID: 31795035
[TBL] [Abstract][Full Text] [Related]
5. Frontal and rostral anterior cingulate (rACC) theta EEG in depression: implications for treatment outcome?
Arns M; Etkin A; Hegerl U; Williams LM; DeBattista C; Palmer DM; Fitzgerald PB; Harris A; deBeuss R; Gordon E
Eur Neuropsychopharmacol; 2015 Aug; 25(8):1190-200. PubMed ID: 25936227
[TBL] [Abstract][Full Text] [Related]
6. Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report.
van Dinteren R; Arns M; Kenemans L; Jongsma ML; Kessels RP; Fitzgerald P; Fallahpour K; Debattista C; Gordon E; Williams LM
Eur Neuropsychopharmacol; 2015 Nov; 25(11):1981-90. PubMed ID: 26282359
[TBL] [Abstract][Full Text] [Related]
7. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
Citrome L
J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965
[TBL] [Abstract][Full Text] [Related]
8. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
[TBL] [Abstract][Full Text] [Related]
9. EEG alpha asymmetry as a gender-specific predictor of outcome to acute treatment with different antidepressant medications in the randomized iSPOT-D study.
Arns M; Bruder G; Hegerl U; Spooner C; Palmer DM; Etkin A; Fallahpour K; Gatt JM; Hirshberg L; Gordon E
Clin Neurophysiol; 2016 Jan; 127(1):509-519. PubMed ID: 26189209
[TBL] [Abstract][Full Text] [Related]
10. Frontoparietal Activation During Response Inhibition Predicts Remission to Antidepressants in Patients With Major Depression.
Gyurak A; Patenaude B; Korgaonkar MS; Grieve SM; Williams LM; Etkin A
Biol Psychiatry; 2016 Feb; 79(4):274-81. PubMed ID: 25891220
[TBL] [Abstract][Full Text] [Related]
11. Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine.
Matrisciano F; Bonaccorso S; Ricciardi A; Scaccianoce S; Panaccione I; Wang L; Ruberto A; Tatarelli R; Nicoletti F; Girardi P; Shelton RC
J Psychiatr Res; 2009 Jan; 43(3):247-54. PubMed ID: 18511076
[TBL] [Abstract][Full Text] [Related]
12. Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
Shilyansky C; Williams LM; Gyurak A; Harris A; Usherwood T; Etkin A
Lancet Psychiatry; 2016 May; 3(5):425-35. PubMed ID: 26995298
[TBL] [Abstract][Full Text] [Related]
13. Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
Kircanski K; Williams LM; Gotlib IH
Depress Anxiety; 2019 Jan; 36(1):63-71. PubMed ID: 30311742
[TBL] [Abstract][Full Text] [Related]
14. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
O'Connell CP; Goldstein-Piekarski AN; Nemeroff CB; Schatzberg AF; Debattista C; Carrillo-Roa T; Binder EB; Dunlop BW; Craighead WE; Mayberg HS; Williams LM
Am J Psychiatry; 2018 Mar; 175(3):251-261. PubMed ID: 29241359
[TBL] [Abstract][Full Text] [Related]
16. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial.
Arnow BA; Blasey C; Williams LM; Palmer DM; Rekshan W; Schatzberg AF; Etkin A; Kulkarni J; Luther JF; Rush AJ
Am J Psychiatry; 2015 Aug; 172(8):743-50. PubMed ID: 25815419
[TBL] [Abstract][Full Text] [Related]
17. A cognitive-emotional biomarker for predicting remission with antidepressant medications: a report from the iSPOT-D trial.
Etkin A; Patenaude B; Song YJ; Usherwood T; Rekshan W; Schatzberg AF; Rush AJ; Williams LM
Neuropsychopharmacology; 2015 May; 40(6):1332-42. PubMed ID: 25547711
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Rao Y; Yang R; Zhao J; Cao Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 51(4):480-490. PubMed ID: 37202104
[TBL] [Abstract][Full Text] [Related]
19. Lisdexamfetamine dimesylate augmentation for adults with major depressive disorder and inadequate response to antidepressant monotherapy: Results from 2 phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Richards C; McIntyre RS; Weisler R; Sambunaris A; Brawman-Mintzer O; Gao J; Geibel B; Dauphin M; Madhoo M
J Affect Disord; 2016 Dec; 206():151-160. PubMed ID: 27474961
[TBL] [Abstract][Full Text] [Related]
20. Prediction of nonremission to antidepressant therapy using diffusion tensor imaging.
Grieve SM; Korgaonkar MS; Gordon E; Williams LM; Rush AJ
J Clin Psychiatry; 2016 Apr; 77(4):e436-43. PubMed ID: 27137427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
